A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Eli Lilly and Company
Massachusetts General Hospital
Kedrion S.p.A.
Ossium Health, Inc.
Nantes University Hospital
Stanford University
Zhejiang University
University of Colorado, Denver
Massachusetts General Hospital
Dana-Farber Cancer Institute
Kelonia Therapeutics, Inc.
Zhejiang University
University of Southern California
Azienda USL Reggio Emilia - IRCCS
Cogent Biosciences, Inc.
Universitair Ziekenhuis Brussel
University of Leipzig
Vincerx Pharma, Inc.
Shenzhen University General Hospital
University Health Network, Toronto
Meyer Children's Hospital IRCCS
AO GENERIUM
Hellenic Society of Hematology
iSpecimen Inc